The Directors of your Company have pleasure to present 53^rd Annual Report along with the Audited Financial Statements
for the financial year ended 31^st March, 2025.

FINANCIAL SUMMARY:

The highlights of financial performance of the Company, for the year ended March 31,2025, are summarized hereunder:

? in Lakhs

Global and Domestic Economic Overview

The Company extends its gratitude to all shareholders on the completion of yet another successful year of operations.
Due to a marginal decline in gelatine and ossein exports, the Company achieved revenue of ? 20,620/-lakhs, in its 53rd
year of operations. The Board remains confident that with continued innovation, prudent management, and the support
of our valued employees, vendors, and customers, the growth trajectory will be further strengthened in the coming
years.

During FY 2024-25, gelatine sales declined by 6% and ossein sales by 4%.due to reduction in selling price While
these fluctuations reflect global market dynamics, the underlying demand for our core products remains robust, and the
Company is actively pursuing opportunities to expand both its product portfolio and market presence.

On the macroeconomic front, India has once again reaffirmed its position as one of the fastest-growing major
economies, registering a 7.4% YOY GDP growth in FY 2025, with Q4 growth at 6.5% (March 2025), strong consumption,
government-led reforms, and robust industrial activity continue to drive this growth momentum.

Globally, whole demand for the various type of gelatine continues to grow, due to surplus production South America and
Turkey and price have common underproduction to with its energetic domestic demand and competitive manufacturing
capabilities, India has emerged as a strategic participant in this growth story, positioning itself as a major force in the
Asia-Pacific market.

Importantly, the Company has taken decisive steps in sustainability and energy efficiency, aligning its operations with
national and global priorities. During the year, the Company reduced its reliance on natural gas, optimized power
consumption through its solar energy plant, and introduced energy-efficient blowers and fine-bubble aeration technology.
These initiatives not only reduced the Company's carbon footprint but also strengthened its competitiveness by lowering

costs and ensuring resource efficiency.

Looking ahead, India in 2026 is envisioned as a rapidly developing economy, committed to sustainable and inclusive
growth. The nation is addressing key challenges in manufacturing, energy transition, and employment generation, while
strategically positioning itself in the global economic and geopolitical landscape.

Particularly promising is India's pharmaceutical industry, which is set for significant transformation by 2026. With strong
government initiatives, technological adoption, and an emphasis on innovation, India is reinforcing its position as a
global pharmaceutical powerhouse, opening new avenues of opportunity for allied industries, including gelatine and
collagen.

Raw Materials

For gelatine manufacturers, the quality and availability of raw materials are critical to maintaining stable operations,
consistent product quality, and financial performance. During the year, the domestic raw material supply chain in India
continued to present challenges, with inconsistency in quality and pricing pressures impacting the industry. Recognizing
these challenges, the Company has taken proactive steps by importing higher-quality raw materials and actively
collaborating with peers and government bodies to enhance domestic standards. These initiatives not only safeguard
product integrity but also support long-term sustainability of operations.

In the global market, Porcine hides and bones remain a dominant raw material source in Europe due to their abundance
and cost-effectiveness, producing Type A gelatine through acid treatment. Meanwhile, bovine hides are increasingly
being used worldwide for Type B gelatine (alkaline treatment), benefiting from their complex collagen structure. Despite
this increase in global availability of gelatine, demand for bovine bone gelatine—India's unique specialty—is expected
to remain steady, with India continuing to serve as a reliable supplier in international markets. Prices, however, are
anticipated to remain subdued due to overall abundance in supply.

Other critical raw materials remained stable during the year:

• Hydrochloric Acid (HCL): Supply and prices were consistent. The Central Pollution Control Board (CPCB) has
advised that industrial materials used in consumables must be approved by FDA and FSSAI. The Company is
engaged in constructive discussions with authorities and expects a favorable resolution soon.

• Lime: Availability was stable, though prices fluctuated—declining until Q3 before rising in Q4 - primarily due to
changes in energy costs for hydrated lime production.

With these strategic sourcing initiatives and premium product positioning, the Company is well-placed to ensure
cost stability, maintain high-quality standards, and capture growth opportunities in FY 2025-26 and beyond.

Financial Summary

For the fiscal year 2024-25, the Company recorded :

• Gelatine Sales: ?12,322 lakhs (net of duties & taxes), reflecting a 6% decline compared to the previous year.

• Ossein Sales: ?2,022 lakhs, a 4% decrease from the previous year.

While these results mirror industry-wide challenges, they also highlight the Company's strategic emphasis on
strengthening its gelatine business.

In contrast, DCP sales remained steady at ?4,297 lakhs in FY 2024-25, compared with ?4,266 lakhs in FY 2023-24,
demonstrating stability in this segment.

Export sales for the year stood at ?12,006 lakhs, compared with ?14,285 lakhs in FY 2023-24, reflecting a decline
of 16%. The reduction was largely driven by global price trends and currency fluctuations. However, the Company
continues to maintain a loyal international customer base, and overseas markets remain a key growth driver due to
higher realizations and strong demand for quality Indian gelatine.

Despite near-term fluctuations, the Company's diversified portfolio, steady DCP performance, and strong export
linkages position it well to capture future growth opportunities, while strategic cost efficiencies and premium product
positioning are expected to further strengthen margins in FY 2025-26.

Operations

During the year, operational performance reflected both challenges and improvements. Imported gel bones delivered
marginally better yields, while crushed bone yields were similar to the previous year but at a higher cost, resulting in
elevated production expenses that affected gelatine margins. Exchange rate fluctuations between the US dollar and
Indian rupee also influenced revenue outcomes.

Production of gelatine increased year-on-year, while ossein and DCP production registered modest growth.

On the efficiency front, power costs were reduced by 5%, primarily due to the stable and effective operation of the
Company's solar plant. Further gains were realized through enhanced efficiency of the hot air generator, supporting
lower energy consumption.

Environmental Initiatives & Sustainability

The year under review has been a landmark in the Company's sustainability journey. With the commissioning of capture
of solar power plant.

Additional initiatives included:

• Energy-efficient blowers installed across operations

• Adoption of fine bubble aeration technology in effluent treatment

Together, these measures have led to a substantial reduction in the Company's carbon footprint, strengthening its
commitment to environmentally responsible operations while ensuring long-term cost competitiveness.

MANAGEMENT DISCUSSION AND ANALYSIS REPORT:

Management Discussion and Analysis Report for the year under review, as stipulated under Regulation 34 read
with Schedule V to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (“Listing Regulations”), is annexed herewith as “Annexure-A” forming part of the Annual Report.

DIVIDEND:

Your directors have recommended Final Dividend of @ 50% i.e. ? 5.00 per share for the financial year ended 31st
March, 2025.

The said Final Dividend is subject to the approval of the Members at the ensuing Annual General Meeting (“AGM”)
scheduled to be held on Wednesday, 24^th September, 2025 at 11.00 a.m. According to the Finance Act, 2020, dividend
income will be taxable in the hands of the Members w.e.f. April 01,2020, and the Company is required to deduct tax at
source from the dividend paid to the Members at prescribed rates as per the Income Tax Act, 1961.

TRANSFER TO RESERVES:

Your Directors has approved a transfer of Rs.104.72 Lakhs to the General Reserve for the year ended March 31, 2025.
SHARE CAPITAL:

As on March 31, 2025, the authorised share capital of the Company was ?12,50,00,000 consisting of 1,25,00,000
equity shares of face value ?10 each and the Issued, Subscribed and Paid-up equity share capital was ? 7,09,23,000
consisting of 70,92,300 equity shares of face value ?10 each.

There was no change in the capital structure of the Company during the year.

TAXATION:

The Company has made a provision of ? 453.10 Lakhs towards current year's Income Tax.

FINANCE:

The Company continues to get requisite assistance and co-operation from its bankers as and when needed.
INSURANCE:

All the properties of the Company including building, plant and machinery and stocks have been adequately covered
under insurance.

INDUSTRIAL RELATIONS:

Industrial relations continued to remain cordial and satisfactory.

PUBLIC DEPOSITS:

During the financial year 2024-2025, your Company has not accepted any deposits within the meaning of Sections 73

& 74 of the Companies Act, 2013 read together with the Companies (Acceptance of Deposits) Rules, 2014. Therefore,
the “details of deposits which are not in compliance with the requirements of Chapter V of the Act” are not applicable
to the Company.

CORPORATE GOVERNANCE:

Good corporate governance underpins the way we conduct business. Your Directors affirm their continued commitment
to the highest level of corporate governance practices. Your Company fully adheres to the standards set out by the
SEBI for corporate governance practices.

The Executive Director and Chief Financial Officer have certified to the Board with regard to the financial statements
and other matters as required under regulation 17(8) of the SEBI Listing Regulations.

The Corporate Governance Report including the General Shareholder Information, as prescribed under Schedule V to
the SEBI Listing Regulations, duly approved by the Board of Directors, which form an integral part of this Report, is set
out as separate Annexure, together with the Certificate from the Practicing Company Secretaries regarding compliance
with the requirements of Corporate Governance as stipulated under various regulations of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015.

SECRETARIAL STANDARDS:

The Company has devised proper systems to ensure compliance with the provisions of all applicable Secretarial
Standards issued by the Institute of Company Secretaries of India and that such systems are adequate and operating
effectively. The company has complied with SS-1 and SS-2.

Transfer of Unclaimed Dividend and Shares to Investor Education and Protection Fund (‘IEPF')

Pursuant to the provisions of the Companies Act, 2013 read with Investor Education Protection Fund Authority
(Accounting, Audit, Transfer and Refund) Rules, 2016, as amended, the dividends, unclaimed for a period of seven
years from the date of transfer to the Unpaid Dividend Account of the Company are liable to be transferred to the
IEPF. Accordingly, unclaimed dividends of Shareholders for the Financial Year 2017-18 lying in the unclaimed dividend
account of the Company as on October 31, 2025 will be transferred to IEPF on the due date. Further, the shares
(excluding the disputed cases having specific orders of the Court, Tribunal or any Statutory Authority restraining such
transfer) pertaining to which dividend remains unclaimed for a consecutive period of seven years from the date of
transfer of the dividend to the unpaid dividend account is also mandatorily required to be transferred to the IEPF
Authority established by the Central Government. Accordingly, the Company has transferred unclaimed dividend and
eligible Shares to IEPF Demat Account within statutory timelines.

The details of unclaimed dividends and shares transferred to IEPF during Financial Year 2024-2025 are as follows:

The Company has sent individual communication to the concerned shareholders at their registered address, whose
dividend remained unclaimed and whose shares were liable to be transferred to the IEPF. The communication was also
published in newspapers.

Any person whose unclaimed dividend and shares pertaining thereto, matured deposits, matured debentures,
application money due for refund, or interest thereon, sale proceeds of fractional shares, redemption proceeds of
preference shares, amongst others has been transferred to the IEPF Fund can claim their due amount from the IEPF
Authority by making an electronic application in e-form IEPF-5 in accordance with the prescribed procedure and on
submission of such documents as prescribed under the IEPF Rules. The process for claiming the shares/unclaimed
dividends out of IEPF can be accessed on the IEPF website at www.iepf.gov.in and on the website of the Company at
www.indiagelatine.com. Pursuant to the provisions of Investor Education and Protection Fund Authority (Accounting,
Audit, Transfer and Refund) Rules, 2016, the Company has uploaded the details of unpaid and unclaimed amounts
lying with the company which are liable to be transferred, on the website of the Company.

Ms. Tanaya Tulsi Daryanani, the Company Secretary and Compliance Officer of the Company is designated as the
Nodal Officer under the provisions of IEPF. The contact details can be accessed on the website of the Company at
www.indiagelatine.com.

SUBSIDIARIES, ASSOCIATES AND JOINT VENTURE COMPANIES

Your Company is not having any subsidiary, associate or joint venture. Further during the financial year under review,
no company has become or ceased to be subsidiary, joint venture or associate of the Company.

DIRECTORS' RESPONSIBILITY STATEMENT:

Based on the framework of internal financial controls and compliance systems established and maintained by the
Company, work performed by the internal, statutory and secretarial auditors and the reviews performed by Management
and the relevant Board Committees, including the Audit Committee, the Board is of the opinion that the Company's
internal financial controls were adequate and effective during the financial year.

According to Section 134(3)(c) read with Section 134(5) of the Companies Act, 2013 in the preparation of annual
accounts for the year ended on 31st March, 2025, the Board of Directors, to the best of their knowledge and belief,
states that:

i) in the preparation of the annual accounts, the applicable accounting standards or any addendum thereto, have
been followed and there are no material departures;

ii) the directors have selected such accounting policies and applied them consistently and made judgments and
estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company
at the end of the financial year and of the profit of the Company for the year ended on that date;

iii) the directors have taken proper and sufficient care for the maintenance of adequate accounting records in
accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing and
detecting fraud and other irregularities;

iv) the directors have prepared the annual accounts on a going concern basis;

v) proper internal financial controls were in place and that the financial controls are adequate and were operating
effectively;

vi) proper systems to ensure compliance with the provisions of all applicable laws were in place and that such
systems were adequate and operating effectively.

AUDITORS AND AUDITORS' REPORT

Statutory Auditors:

The Statutory Auditors M/s Mahendra N. Shah & Co., Chartered Accountants, Firm Registration No: 105775W, were
appointed by the members of the Company in 50^th Annual General Meeting, to hold office from the conclusion of
50^th Annual General meeting for a term of consecutive five years till conclusion of 55^th Annual General Meeting to
be held in the year 2027 in terms of the applicable provisions of Section 139(1) of the Act read with the Companies
(Audit and Auditors) Rules, 2014. In terms of the Notification issued by the Ministry of Corporate Affairs dated 7^th
May, 2018, the proviso requiring ratification of the Auditors appointment by the shareholders at each AGM has been
omitted. Accordingly, the ratification of appointment of Statutory Auditors would not be required at the ensuing AGM and
M/s Mahendra N. Shah & Co., Chartered Accountants, Firm Registration No: 105775W would continue to act as the
Statutory Auditors of the Company for five years upto the conclusion of the 55^th AGM to be held in 2027.

AUDITORS' REPORT

The report of the Statutory Auditors along with notes to financial statements is enclosed to this Annual Report. Notes on
financial statements referred to in the Auditors' Report are self-explanatory and do not call for any further comments.
The Auditor's Report does not contain any qualification, reservation or adverse remarks.

Disclosure under Section 143(12) of the Act

During the year under review, the Auditors have not reported to the Audit Committee or the Board any instances of fraud
or irregularities against the Company by its officers or employees, under Section 143 (12) of the Companies Act, 2013
and Rules made there under, the details of which would need to be mentioned in the Board's report, which forms part
of this Annual Report.

SECRETARIAL AUDITOR AND AUDIT REPORT:

Pursuant to the provisions of Section 204 of the Companies Act, 2013 read with the Companies (Appointment and
Remuneration of Managerial Personnel) Rules, 2014 your Company has appointed M/s. Samdani Shah & Kabra,
Practicing Company Secretaries to conduct the Secretarial Audit of your Company for the financial year ended 31^st

March, 2025.

Secretarial Audit Report has been issued by M/s. Samdani Shah & Kabra, Practicing Company Secretaries in Form
MR-3. The said report does not contain any observation or qualification requiring explanation or adverse remark. The
Secretarial Audit report is annexed herewith as “Annexure-E” to this report.

Pursuant to regulation 24A (2) of the SEBI Listing Regulations, 2015, read with SEBI Circular CIR/CFD/CMD1/27/2019
dated 8^th February, 2019, M/s Chirag Shah & Associates, Practicing Company Secretaries has submitted Annual
Secretarial Compliance Report for the financial year 2024-25 and has also confirmed that the Company has complied
with all applicable SEBI Regulations and circulars / guidelines issued thereunder. The said Annual Secretarial
Compliance Report was submitted with the stock exchange within the given timeframe & made available on the website
of the Company.

POLICY ON DIRECTORS' APPOINTMENT AND REMUNERATION:

(Including criteria for determining qualification, positive attributes, independence of a Director, policy relating to
remuneration of Directors, Key Managerial Personnel and other employees)

(a) Policy on Directors' Appointment

The Board has put in place a policy on appointment of Directors and remuneration including criteria for determining
qualifications, positive attributes, independence of a Director as required under Section 178(3) of the Act.

The said Nomination and Remuneration Policy, inter alia, is directed to work as guiding principles on qualifications,
positive attributes and independence for the appointment of a Director, remuneration for the Directors, Key Managerial
Personnel and Senior Management Personnel, performance evaluation of all Directors and achieving the benefits of
having a diverse Board. The Guidelines lay down the following:

• Composition and Role of the Board (Role of the Chairman, Directors, size of the Board, Managing Director,
Executive Director, Non-Executive Directors, Independent Directors, their term, tenure and directorship)

• Board appointment

• Directors' Remuneration

• Code of Conduct (Managing Director, Executive Director, Non-Executive Directors, Independent Directors)

• Board effectiveness review

The aforesaid policy of the Company on Directors' appointment and remuneration, under Section 178(3) of Companies
Act, 2013 is available on our website i.e. www.indiagelatine.com or on below mentioned weblink:

http://www.indiagelatine.com/financial/Nomination%20&%20Remuneration%20Policv 2023.pdf

ANNUAL EVALUATION BY THE BOARD OF ITS OWN PERFORMANCE, ITS COMMITTEES AND INDIVIDUAL
DIRECTORS:

The Company has adopted a process for performance evaluation of the Board and its Committees & performance of
each of the Directors. The evaluation criteria include inter alia, structure of the Board, qualifications, experience and
competency of Directors, diversity in Board, quality of relationship between the Board and management, meetings of
the Board.

Pursuant to provisions of the Companies Act, 2013 and Regulation 17(10) of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, the Directors on the Board carried out an annual evaluation of the Board itself,
its Committees and individual Directors. The entire Board carried out performance evaluation of each Independent
Director excluding the Independent Director being evaluated. Nomination and Remuneration Committee also carried
out evaluation of every Director's performance.

A structured questionnaire was prepared after taking into consideration inputs received from the Directors, setting out
parameters of evaluation. Evaluation parameters of the Board and Committees were mainly based on Disclosure of
Information, Key functions of the Board and Committees, responsibilities of the Board and Committees, Corporate
Governance Norms etc. Evaluation parameters of individual directors including the Chairman of the Board and
Independent Directors were based on knowledge to perform the role, time and level of participation, performance of
duties and level of oversight and professional conduct etc.

Pursuant to the provisions of the Act and Regulation 25(4) of SEBI Listing Regulations, Independent Directors in their

separate meeting held on 28^th February, 2025 have also evaluated the performance of Non-Independent Directors,
Chairman of the Board and the Board as a whole.

DISCLOSURES BY THE DIRECTORS:

The Directors on the Board have submitted notice of interest under Section 184(1), intimation under Section 164(2)
and declaration as to compliance with the Code of Conduct of the Company. All Independent Directors have also given
declarations that they meet the criteria of independence as laid down under Section 149(6) of the Companies Act, 2013
(the “Act”) and Regulation 16(1)(b) of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“SEBI Listing Regulations”).

The Independent Directors have complied with the code of Independent Directors as prescribed in Schedule IV of
the Companies Act, 2013. In the opinion of the Board, the Independent Directors possess the requisite expertise and
experience (including the proficiency) and are persons of high integrity and repute. They fulfil the conditions specified
in the Act and the Rules made thereunder and are independent of the management.

The Independent Directors have confirmed that they have registered their names in the data bank maintained with the
Indian Institute of Corporate Affairs ('IICA') and have completed the online proficiency self-assessment test conducted
by the Institute notified under the section 150(1) of the Act.

The Directors and Senior Management Personnel have complied with the code of conduct for Directors and Senior
Management.

NUMBER OF MEETING OF BOARD OF DIRECTORS:

The Board of Directors duly met 8 times and the independent Directors twice (28.02.2025 and 12.03.2025) during the
financial year ended March 31, 2025. The dates on which the Board meetings were held are 30.04.2024, 08.08.2024,
22.10.2024, 11.11.2024, 05.12.2024, 31.01.2025, 10.02.2025, 31.03.2025.

The other details of which are mentioned in the Corporate Governance Report annexed herewith. The intervening
gap between the meetings was within the period prescribed under the Companies Act, 2013 and the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015.

DETAILS OF COMMITTEE OF DIRECTORS:

As required under the Act and the SEBI Listing Regulations, the Company has formed all the statutory committees. The
Composition of Audit Committee of Directors, Nomination and Remuneration Committee of Directors, Corporate Social
Responsibility Committee and Stakeholder Relationship Committee, number of meetings held of each Committee
during the financial year 2024-25 and meetings attended by each member of the Committee as required under the
Companies Act, 2013 are provided in Corporate Governance Report and forming part of the report.

There have been no instances where the Board did not accept the recommendations of its committees, including the
Audit Committee.

DIRECTORS & KEY MANAGERIAL PERSONNEL:

DIRECTORS

Pursuant to the provisions of Section 152(6) of the Companies Act, Mr. Annamalai Sankaralingam (DIN: 00001381),
Director who retires by rotation and being eligible, offers himself for re-appointment.

KEY MANAGERIAL PERSONNEL

During the year under review, the following were the 'Key Managerial Personnel' of the Company:

a) Mr. Viren C. Mirani - Chairman (upto 31^stJanuary 2025 &

Managing Director (upto 31^st March 2025);

b) Ms. Vishakha H. Purohit - Chief Financial Officer

d) Mrs. Tanaya T Daryanani - Company Secretary.

INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY

The Company has proper and adequate internal control systems to ensure that all assets are safeguarded and
protected against loss from unauthorized use or disposition and those transactions are authorized, recorded and
reported correctly.

The Internal Auditor monitors and evaluates the efficacy and adequacy of internal financial control system in the
Company, its compliance with operating systems, accounting procedures, application of the instructions and policies
fixed by the senior management of the Company. The Audit Committee reviews the report submitted by the Internal
Auditors on a quarterly basis. During the Audit Process no material discrepancies have been reported by the Internal
Auditor.

LOANS, INVESTMENT AND GUARANTEES BY THE COMPANY:

As required to be reported pursuant to the provisions of Section 186 and Section 134(3)(g) of the Companies Act, 2013,
the particulars of loans and/or investments made by the Company under the aforesaid provisions during the Financial
Year 2024-25 have been provided in the Notes to the Standalone Financial Statements.

MATERIAL CHANGES AND COMMITMENTS, IF ANY AFFECTING THE FINANCIAL POSITION OF THE COMPANY:

There are no material changes and commitments, affecting the financial position of the Company which has occurred
between the close of the Financial Year as on March 31, 2025, to which the Financial Statement relate and the date of
this Report.

PARTICULARS ON REMUNERATION

The remuneration paid to Directors, Key Managerial Personnel (“KMP”), and Senior Management Personnel (“SMP”)
during Financial year ended 31^st March, 2025 was in accordance with the Nomination and Remuneration Policy of the
Company.

The prescribed particulars of Employees required under Section197(12) of the Companies Act, 2013 read with Rule
5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is annexed herewith as
“Annexure-B” to this Report.

The information required under Section 197(12) of the Companies Act, 2013 read with Rule 5(2) and 5(3) of the
Companies (Appointment and Remuneration of Managerial Personnel) Rules,2014 and forming part of the Boards'
Report for the year ended 31^st March, 2025 is given in the “Annexure B” of this Report.

ANNUAL RETURN:

Pursuant to Section 92(3) read with Section 134(3)(a) of the Companies Act, as amended from time to time, the Annual
Return as on March 31, 2024 in the form MGT-7 is available on the Company's website at the web-link given below:

https://www.indiagelatine.com/financial/DRAFT MGT 7 23-24 PDF.pdf

RELATED PARTY TRANSACTIONS:

All related party transactions that were entered into during the financial year were on an arm's length basis and in the
ordinary course of business and were in compliance with the applicable provisions of the Act and the Listing Regulations.
Pursuant to clause (h) of sub-section (3) of Section 134 of the Act and Rule 8(2) of the Companies (Accounts) Rules,
2014, the details of contracts / arrangements entered with related parties in prescribed Form AOC-2, is enclosed with
this Report as “Annexure- F”. There are no materially significant Related Party Transactions made by the Company
with Promoters, Directors, Key Managerial Personnel or other designated persons which may have a potential conflict
with the interest of the Company at large.

The Company has formulated and adopted a policy on dealing with related party transactions, in line with Regulation 23
of the Listing Regulations, which is uploaded on the Company's website at the web-link given below:

http://www.indiagelatine.com/financial/Policv%20on%20Materialitv%20of%20related%20partv%20transaction%20

updated.pdf

As a part of the mandate under the Listing Regulations and the terms of reference, the Audit Committee undertakes
quarterly review of related party transactions entered into by the Company with its related parties. Pursuant to Regulation
23 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Section 177 of the Companies
Act, 2013, the Audit Committee has granted omnibus approval in respect of transactions which are repetitive in nature,
which may or may not be foreseen, not exceeding the limits specified thereunder.

RISK MANAGEMENT

Pursuant to Section 134 of the Act, the Company has adopted a risk management policy to identify, analyze, evaluate
& categorize various risks, implement measures to minimize/mitigate the impact of these risks where it is deemed
necessary and possible and a process to monitor them on a regular basis with strategy and business planning.

The Company periodically reviews the risks and suggests steps to be taken to control and mitigate the same through
a properly defined framework.

VIGIL MECHANISM/ WHISTLE BLOWER POLICY:

Pursuant to the provisions of sub-section 9 of section 177 of Companies Act. 2013 (“the Act” or “Act”) and in terms
of Regulation 22 read with Regulation 4(2)(d)(iv) of Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 (“SEBI LODR”), the Company has a vigil mechanism named Whistle
Blower Policy to deal with instance of fraud and mismanagement and provide a mechanism for the Directors / Employees
of the Company to approach the designated persons / Chairman of the Audit Committee of the Company to, inter alia,
report to the management instances of unethical behavior, actual or suspected fraud or violation of the company's code
of conduct or ethics policy.

The details of the Whistle Blower Policy are provided in the Corporate Governance Report and policy is also uploaded
on the Company's website at the web-link given below:

http://www.indiagelatine.com/financial/Whistle%20blower%20policv%20as%20per%20LQDR.pdf
CORPORATE SOCIAL RESPONSIBILITY INITIATIVES:

Corporate Social Responsibility ('CSR') Committee has been constituted pursuant to Section 135 of the Companies
Act, 2013. Detailed information about composition of the Committee, details of meetings held, attendance etc. along
with the brief outline of the Corporate Social Responsibility (CSR) Policy of the company and the initiatives undertaken
by the company on CSR activities during the year are set out in Annexure of this Report in the format prescribed in the
Companies (Corporate Social Responsibility Policy) Rules 2014 as “Annexure-D” and forms an integral part of the
Report.

The Corporate Social Responsibility (CSR) Policy is available on the website of the Company i.e. www.indiagelatine.com
COST RECORDS AND COST AUDIT:

Maintenance of cost records and requirement of cost audit as prescribed under the provisions of Section 148(1) of the
Companies Act, 2013 are not applicable for the business activities carried out by the Company.

DISCLOSURE UNDER SEXUAL HARRASMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION
AND REDRESSAL) ACT, 2013:

The Company has zero tolerance towards sexual harassment at the workplace. The Company has adopted a Policy
on Prevention, Prohibition and Redressal of Sexual Harassment at Workplace in line with the provisions of the Sexual
Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 and the Rules thereunder.

The Company has complied with the provisions relating to the constitution of the Internal Complaints Committee as per
the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013.

During the reporting year, no complaint has been received with respect to sexual harassment.

SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS:

There have been no significant and material orders passed by the regulators or courts or tribunals impacting the going
concern status and the Company's future operations.

PROCEEDINGS UNDER THE INSOLVENCY AND BANKRUPTCY CODE, 2016:

No proceedings have been initiated during the year or are pending against the Company as at March 31, 2025, under
the Insolvency and Bankruptcy Code, 2016 as amended, before the National Company Law Tribunal or other Courts.

CHANGE IN NATURE OF BUSINESS OF COMPANY:

There is no change in the nature of business of your Company during the year under review.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND
OUTGO:

The information on conservation of energy, technology absorption and foreign exchange earnings and outgo as
stipulated under sub-section (3)(m) of Section 134 of the Companies Act, 2013, read with the Companies (Accounts)
Rules, 2014, is set out herewith as “Annexure C” to this Report.

PREVENTION OF INSIDER TRADING:

The Company has adopted a Code of Fair Disclosure as per regulation 8(1) & (2) and Code of Conduct as per
regulation 9(1) & (2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 for Prevention of Insider Trading
with a view to regulate trading in securities by the Directors and designated employees of the Company. The code
requires pre- clearance for dealing in the Company's Shares and prohibits the purchase or sale of Company shares by
the Directors and the designated employees while in possession of unpublished price sensitive information in relation
to the Company and during the period when the trading window is closed. All Directors and designated employees have
confirmed compliance with the code.

ACKNOWLEDGEMENT:

Your Directors wish to express their grateful appreciation for the devoted services of the workers, staff and executives
for their ardent enthusiasm and interminable efforts thereby contributing to the efficient management of the affairs of
the Company.

Your directors place on record their gratitude to the State and Central Government, the company's Bankers, Customers,
Suppliers and Shareholders for their co-operation and support and look forward to their continued support in the future.

For and on behalf of the Board of Directors

Annamalai Sankaralingam

Place: Mumbai Chairman

Date: 22.05.2025 (DIN: 00001381)